Shortage of Prostate Cancer Drug; Win for DBT Mammo; Double Lung Transplant

(MedPage Today) -- Lutetium Lu 177 vipivotide tetraxetan (Pluvicto) is currently in shortage, according to the FDA, leaving some prostate cancer patients with limited options; the drug's manufacturer Novartis said it's working to increase production...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news